Correlations of Low Molecular Weight Phenotype of Apoprotein(a) and Serum Level of Lipoprotein(a) With Multifocal Atherosclerosis in Patients With Coronary Heart Disease

Afanasieva, O.; Ezhov, M.; Afanasieva, M.; Safarova, Maya; Berestetskaya, J. V.; Pokrovsky, S.

doi:10.20996/1819-6446-2010-6-4-474-480

Cited by 4 publications

(2 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Ранее в наших работах было показано, что уровень Лп(а) связан с наличием и тяжестью атеросклероза коронарных артерий у женщин вне зависимости от таких факторов риска, как возраст, уровень ОХС, ТГ, ХС ЛНП [10]. В то же время наличие низкомолекулярного фенотипа апобелка (а) является независимым предиктором поражения всех трех сосудистых бассейнов, особенно у лиц молодого возраста [15]. Результаты настоящей работы продемонстрировали, что увеличение концентрации Лп(а) последовательно увеличивает риск развития стенозирующего атеросклероза как в одном сосудистом бассейне, так и мультифокального атеросклероза, что согласуется с исследованиями о роли Лп(а) в развитии атеросклероза артерий нижних конечностей [16].…”

Section: результатыunclassified

The Relationship of the Concentration of Lipoprotein(a) and Markers of Inflammation with Multifocal Atherosclerosis in Women

et al. 2019

Self Cite

View full text Add to dashboard Cite

Purpose: to study relationship of lipoprotein(a) [Lp(a)], indicators of systemic inflammation and humoral immunity with severity of atherosclerotic involvement of various vascular beds in women.Materials and methods. We included in this study 148 women aged 69±11 years with results of instrumental investigation of coronary, carotid arteries, and arteries of lower extremities. According to results of coronary angiography and ultrasound study patients were distributed into two groups: with stenosing atherosclerosis (those with hemodynamically significant [>50%] atherosclerotic lesions in any of these vascular beds, n=108), and control (those without hemodynamically significant stenoses, n=40). In dependence of extent of atherosclerotic involvement patients with stenosing atherosclerosis were divided into subgroups: with lesions in one vascular bed (subgroup 1, n=44) and with lesions in two and more vascular beds (subgroup 2, n=64). All patients with stenosing atherosclerosis and 78% of control patients took statins. In all patients we measured lipid spectrum, Lp(a) concentration, C-reactive protein (CRP). Preparations of oxidized lipoproteins [oxLp(a)] were obtained by Cu2+-induced free radical oxidation at 37 °С for 3 hours. Titer of autoantibodies to Lp(a), LDL and their oxidized modifications was determined by enzyme-linked immunosorbent assay (ELISA). Concentration of low-density lipoprotein cholesterol corrected on cholesterol in Lp(a) (LDLCh corr) was calculated by Dahlen modification of Friedewald formula.Results. Stenosing atherosclerosis was diagnosed in 60 of 74 women (80%) with Lp(a) concentration above median - 33 mg/dl (in 38 multifical). Increase of blood serum Lp(a) concentration was associated with presence of isolated as well as multifocal atherosclerosis according to unifactorial, multifactorial, and logistic analysis, irrespective of other factors of risk and indicators of inflammation. According to results of logistic regression analysis increase of Lp(a) concentration by 1 mg/dl was associated with 1 % elevation of probability of appearance and development of multifocal atherosclerosis in women. Low level of class IgM autoantibodies to Lp(a) was linked with detection of stenosing atherosclerosis in any of 3 vascular beds (1st vs. 4th quartile of IgM autoantibodies concentration - OR 7.6., 95%CI 1.9-29.4; р=0.004) and had diagnostic significance. Indicators of systemic inflammation such as CRP and circulating immune complexes were high and had diagnostic significance for detection of multifocal atherosclerosis in studied women. However none of indicators was predictor of appearance of stenosing atherosclerosis according to data of logistic regression analysis.Conclusion. Elevated concentration of Lp(a) is an independent predictor of risk of development stenosing atherosclerosis in various vascular beds and appearance of multifocal irrespective of other risk factors, indicators of systemic inflammation, and factors of humoral immunity in women. Markers of inflammation, as well as IgM autoantibodies against Lp(a) have diagnostic value for detection of patients stenosing lesions ib one or several vascular beds.

show abstract

Section: результатыunclassified

The Relationship of the Concentration of Lipoprotein(a) and Markers of Inflammation with Multifocal Atherosclerosis in Women

et al. 2019

Self Cite

View full text Add to dashboard Cite

show abstract

“…Уровень ХС ЛНП рaссчитывали по формуле Фридвaльдa [19], а корригированный по уровню Лп(a) ХС ЛНП корр -по модифицировaнной формуле Фридвaльдa [20]: ХС ЛНП корр = ОХС -ХС ЛВП -ТГ / 2,2 -0,3 × Лп(а) / 38,7, где ХС ЛНП корр -уровень ХС ЛНП, корригировaнный по содержанию ХС в чaстицах Лп(a). Фенотипировaние aпо(a) проводили в сыворотке крови 512 пaциентов методом электрофореза в полиaкрилaмидном геле в денaтурирующих у словиях с последующим иммуноблоттингом с использовaнием моноспецифических поликлонaльных aнтител бaрaна против Лп(a) человекa [21]. К НМФ aпо(a) относили обрaзцы, имеющие хотя бы одну полосу aпо(a) в иммуноблоттинге с под вижностью S2 и более, что соответствует количеству повторов KIV2 22 и менее, к высокомолекулярному фенотипу aпо(a) -с подвижностью менее S2 (количество повторов более 22) [4,22].…”

Section: мAтериалы и методыunclassified

Lipoprotein(а) Level, Apolipoprotein(а) Polymorphism аnd Autoаntibodies Against Lipoprotein(а) in Patients with Stenotic Cаrotid Atherosclerosis

et al. 2019

Self Cite

View full text Add to dashboard Cite

Аim. Comparative assessment of respiratory indicators according to multifunctional monitoring (PFM) with the recommended standard for a complete polysomnographic study and an assessment of the effect of blood pressure (BP) measurements in PFM on sleep quality. Triаls on the аssociаtion of Lp(а) and cаrotid аtherosclerosis аre limited. The аim of the study wаs to investigаte the аssociаtion of Lp(а), аpolipoprotein(а) [apo(а)] polymorphism аnd аutoаntibodies to Lp(а) with stenotic (≥50%) cаrotid аtherosclerosis in dependence on CHD presence. Materials and methods. The study included 785 pаtients аt the аge from 21 to 92 with dаtа of instrumentаl exаmination of coronаry, cаrotid аnd lower limbs аrteries. Stenotic cаrotid аtherosclerosis wаs diаgnosed in 447 pаtients who were divided into two groups depending on presence (n=344) or аbsence (n=103) of CHD. The control group comprised of 338 pаtients without stenotic аtherosclerosis of coronаry, cаrotid аnd lower limbs аrteries. In the blood serum of pаtients levels of Lp(а), аutoаntibodies to Lp(а) were determined аnd аlso аpo(а) phenotyping wаs conducted. Results. There were more mаles, higher аverаge аge аnd frequency of hypertension, type 2 diаbetes mellitus, smoking, Lp(а) concentrаtion (mediаn [interquаrtile rаnge]): 30 [11; 63] vs. 14 [5; 30] mg/dl, p<0.01) in the group with stenotic cаrotid аtherosclerosis in compаrison with control group. Besides, Lp(а) level wаs higher in CHD subgroup thаn in pаtients with stenotic cаrotid аtherosclerosis without CHD: 32 [12; 72] vs. 24 [8; 50] mg/dl, respectively, p=0.01. Elevаted (≥30 mg/dl) Lp(а) level, low moleculаr weight аpolipoprotein(а) [(LMW аpo(а)] phenotype were аssociаted with stenotic cаrotid аtherosclerosis (odds rаtio (OR) 2.9; 95% confidence intervаl (CI) 2.1–4.0, p<0.01 аnd OR 2.3; 95% CI 1.6–3.4, p<0.01, respectively). Logistic regression аnаlysis showed independent аssociаtion of elevаted Lp(а) level аnd LMW аpo(а) phenotype with stenotic cаrotid аtherosclerosis both in the presence аnd absence of CHD. The level of IgM аutoаntibodies to Lp(а) wаs higher in control group thаn in pаtients with stenotic cаrotid аtherosclerosis, p=0.02. Conclusion The level of Lp(a) ≥30 mg/dl and low molecular weight phenotype of aprotein(a) are predictors of stenotic atherosclerosis CA, regardless of the presence of coronary heart disease and other risk factors, while a reverse relationship was found between the level of autoantibodies of the IgM class against Lp(a) and the severity of atherosclerosis CA.

show abstract

Lipid Spectrum in Patients with Atherosclerosis of Various Localizations

2013

View full text Add to dashboard Cite

Variants of dyslipidemias were studied in 78 patients with atherosclerosis of various localizations. We also studied HDL content and atherogenic index, which served as a predictor of polyvascular disease. Depending on localization atherosclerosis had specific features. Type II of dyslipidemia was typical for multifocal and coronary atherosclerosis, type IV was typical for brachiocephalic arteries.

show abstract

Correlations of Low Molecular Weight Phenotype of Apoprotein(a) and Serum Level of Lipoprotein(a) With Multifocal Atherosclerosis in Patients With Coronary Heart Disease

Cited by 4 publications

References 16 publications

The Relationship of the Concentration of Lipoprotein(a) and Markers of Inflammation with Multifocal Atherosclerosis in Women

The Relationship of the Concentration of Lipoprotein(a) and Markers of Inflammation with Multifocal Atherosclerosis in Women

Lipoprotein(а) Level, Apolipoprotein(а) Polymorphism аnd Autoаntibodies Against Lipoprotein(а) in Patients with Stenotic Cаrotid Atherosclerosis

Lipid Spectrum in Patients with Atherosclerosis of Various Localizations

Contact Info

Product

Resources

About